Low-protein diet with chemotherapy and radiation for rectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special diet low in two amino acids (serine and glycine) can make standard chemotherapy and radiation more effective for rectal cancer. It aims to see if this dietary change helps shrink tumors and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have locally advanced rectal cancer (stage 2 or 3), confirmed by an MRI.
- You are generally healthy enough to be up and about (ECOG 0 or 1).
- You have no major nutritional problems and can eat or use a feeding tube.
- Your blood cell counts, liver, and kidney function are within acceptable ranges.
- You are not pregnant or breastfeeding and agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of short course radiation therapy, chemotherapy, and two immunotherapy drugs for people with a specific type of rectal cancer that is locally advanced but can still be removed by surgery. It may offer a more effective treatment option for those with mismatch repair proficient (pMMR) or microsatellite stable (MSS) tumors.
This trial tests a short course of radiation with chemotherapy, targeted therapy, and immunotherapy before surgery for locally advanced rectal cancer. It aims to shrink the tumor and improve outcomes.
This trial tests combining immunotherapy with standard chemotherapy and radiation before surgery for locally advanced rectal cancer. It aims to see if this approach can improve outcomes for patients whose tumors have certain genetic features (pMMR or MSS).
This trial tests a combination of short-course radiation, chemotherapy, and two targeted drugs (Serplulimab and Bevacizumab) for people with a specific type of rectal cancer. It aims to see if this treatment can help shrink the tumor enough to avoid surgery and keep the anus.
This study compares two different ways of delivering radiation and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see which approach is more effective and safer for people whose cancer has not spread.
This trial tests whether limiting an amino acid called arginine in the diet, along with standard chemoradiation before surgery, can improve treatment outcomes for people with locally advanced rectal cancer. It aims to make the cancer more responsive to treatment and reduce side effects.
Hear when a new Locally Advanced Rectal Cancer (LARC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.